Posted on 09-17-2012
Did you know the global market for Alzheimer's disease therapeutics could soar to $8 billion once therapies are approved that actually change the course of the disease. According to Genetic Engineering & Biotechnology News from August 2102, the current therapeutic market is valued at $3-4 billion and is shared among drugs that temporarily delay disease progression or address the symptoms but do not alter the underlying disease. Despite all the research on amyloid plaques and neurofibrillary tangles, there is still a debate on whether these biological phenomena are causative or symptomatic of Alzheimer's. Once scientists can clearly and unequivocally define key factors related to the actual biology of the disease itself, therapeutic advances could take place much more quickly. What has been found is that approximately 18% of Alzheimer's patients are severely deficient in Vitamin B12 and when given a shot can actually pull immediately out of even advanced stages of the disease! So if you know someone who suffers from it, I would suggest it to their family....certainly worth a try!
There are no comments for this post. Please use the form below to post a comment.